All In MedTech

FDA Clearance Tracker · P100018-S001

PIPELINE EMBOLIZATION DEVICE

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 27, 2011 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 27, 2011

Approved

Time to decision

60 days

Received Apr 28, 2011. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P100018-S001
Device name
PIPELINE EMBOLIZATION DEVICE
Applicant location
Irvine, CA
Received
Apr 28, 2011
Decided
Jun 27, 2011
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P100018

Device type

Device class
Class III

Every decision under product code OUT

FDA's approval statement

As written in FDA's record.

APPROVAL OF POST- APPROVAL STUDY PROTOCOL.

Source documents

Other decisions for Micro Therapeutics, Inc. d/b/a ev3 Neurovascular

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.